Wire Stories

PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)

Single-arm trial will evaluate an accelerated dosing schedule BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary…

ScottsMiracle-Gro Reports Fiscal 2023 Second Quarter Results

U.S. Consumer First Half Sales of $1.73B in Line with Record Prior Two Years Fiscal…

Nickel 28 Releases Ramu Q1 2023 Operating Performance and Provides Update on Shareholder Engagement

Nickel 28 confirms receipt of largest ever cash distribution from Ramu joint venture of US$9.7…

Radware Reports First Quarter 2023 Financial Results

First Quarter 2023 Financial Results and Highlights Revenue of $69.0 million, down 6% year-over-year Total…

India E-Pharmacy Market Report 2022: Chronic Conditions Segment Dominated the Market in 2021 – Forecasts to 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "E-pharmacy Market in India 2022-2027" report has been added to ResearchAndMarkets.com's offering. It…

India Oil & Gas Industry Report 2023: The Third-largest Crude Oil Importer in the World After the USA and China – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Oil & Gas Industry in India 2023" report has been added to ResearchAndMarkets.com's…

SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is Tapped by Unipath Specialty Laboratory Limited

SOPHiA GENETICS expands footprint in India as Unipath Specialty Laboratory Limited is now live on…